Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeThermo Fisher ScientificNext-Generation Nano, Capillary- & Micro-Flow LC Systems Enhance Productivity & Performance

Next-Generation Nano, Capillary- & Micro-Flow LC Systems Enhance Productivity & Performance

Principal investigators, laboratories, and proteomics researchers in academia, biopharma, and contract research organizations can now benefit from an all-in-one nano-, capillary- and micro-flow liquid chromatography (LC) system. Designed for high sensitivity LC-mass spectrometry (LC-MS) applications, technical capabilities and seamless integration with Thermo Scientific PepMap Neo Columns and Thermo Scientific mass-spectrometry portfolio, the new Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns help users overcome limitations of existing low-flow LC instruments.

“Low-flow LC users are limited by technical capacity and a high level of expertise required for system operation,” said Kent Davidson, vice president, and general manager, high-performance chromatography solutions, Thermo Fisher Scientific. “The Vanquish Neo UHPLC System and PepMap Neo Columns allow for long-term operation at maximum performance levels without compromise. Enhanced ease-of-use and increased versatility enable users to push science forward.”

Professor Bernhard Kuster, Technical University Munich, said, “The Vanquish Neo UHPLC System will transform how scientists perform proteomics studies by providing the long-term robustness and flow-range versatility required for deep and fast LC-MS profiling of thousands of proteomes, while coupled with PepMap Columns and high-resolution accurate mass (HRAM) systems.”

The new Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns deliver application flexibility and robust analytical performance at flow rates from 1 nL/min to 100 µL/min up to 1500 bar. Novice and expert LC-MS users will enjoy accelerated productivity, reduced method overhead time, and long-term operation essential for 24/7 large sample cohort analysis.

Users of the Vanquish Neo UHPLC System and PepMap Neo Columns benefit from:

  • Excellent separation performance, column-to-column reproducibility, and simple operation.
  • Seamless integration with the comprehensive portfolio of Thermo Scientific mass spectrometers.
  • Enhanced quantitation through high-injection volume linearity, precision and accuracy.
  • Negligible system carryover with automated wash routines.
  • System monitoring and control with automated procedures and guided maintenance routines through the Thermo Scientific Vanquish User Interface.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy